Notification of Transactions

Summary by AI BETAClose X

Spire Healthcare Group plc announced that on May 18, 2026, Executive Directors Justin Ash and Harbant Samra exercised vested awards. Justin Ash exercised 547,061 nil-cost options from his 2021 LTIP awards and 116,473 from his 2023 DSBP awards, retaining 289,942 and 61,730 shares respectively after tax, bringing his total holding to 1,652,131 ordinary shares. Harbant Samra exercised 37,463 nil-cost options from his 2023 LTIP awards, retaining 19,855 shares after tax, resulting in a total holding of 74,932 ordinary shares.

Disclaimer*

Spire Healthcare Group PLC
19 May 2026
 

Spire Healthcare Group plc (the Company)

Notification of Transactions of Persons Discharging Managerial Responsibilities

 

 

19 May 2026

 

Exercise of awards

The Company announces that, on 18 May 2026, the Executive Directors of the Company, exercised vested awards as follows:

 

(1)  Justin Ash exercised both his:

·    Long Term Incentive Plan awards in the Company that were granted on 18 March 2021 (the 2021 LTIP awards). 2021 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2023 Annual Report and Accounts. On vesting in March 2024, the 2021 LTIP awards were subject to a further two-year holding period which ended on 19 March 2026; and

·    Deferred Share Bonus Plan awards that were granted on 15 March 2023 (the 2023 DSBP awards). 2023 DSBP awards were subject to a three-year holding period which ended on 15 March 2026; and

 

(2)  Harbant Samra exercised his Long Term Incentive Plan awards in the Company that were granted on 15 March 2023 (the 2023 LTIP awards). 2023 LTIP awards were subject to certain performance metrics that were measured over a three-year period and full details of the outcomes of these were reported in the Company's 2025 Annual Report and Accounts.

 

Following the exercise by the Directors of these awards over ordinary shares in the Company and after the satisfaction of taxes due, both decided to retain the balance of ordinary shares as follows:

 

 

Share plan and type of award

Shares vested and exercised

Shares retained following satisfaction of taxes due

Justin Ash

2021 LTIP (in the form of nil-cost options)

 

547,061

289,942

Justin Ash

 

2023 DSBP (in the form of nil-cost options)

 

116,473

61,730

Total number of shares retained

351,672

 

Following the transactions, Justin Ash holds 1,652,131 ordinary shares in the Company.

 

 

Share plan and type of award

Shares vested and exercised

Shares retained following satisfaction of taxes due

Harbant Samra

2023 LTIP (in the form of nil-cost options)

 

37,463

19,855

Total number of shares retained

19,855

 

Following the transactions, Harbant Samra holds 74,932 ordinary shares in the Company.

Name of contact and telephone number for queries:

Mantraraj Budhdev

Group General Counsel, Chief People Officer and Company Secretary

Spire Healthcare Group plc

Tel: 07787 283848

 

 

Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justin Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Long Term Incentive Plan.

 

Following the exercise by Mr Ash of his award over 547,061 ordinary shares and after the satisfaction of taxes due, a balance of 289,942 ordinary shares were transferred to him, which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

289,942

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2026-05-18

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justin Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Deferred Share Bonus Plan.

 

Following the exercise by Mr Ash of his award over 116,473 ordinary shares and after the satisfaction of taxes due, a balance of 61,730 ordinary shares were transferred to him, which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

61,730

 

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2026-05-18

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Harbant Samra

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Exercise of nil-cost options over ordinary shares vested under the Spire Healthcare Group plc Long Term Incentive Plan.

 

Following the exercise by Mr Samra of his award over 37,463 ordinary shares and after the satisfaction of taxes due, a balance of 19,855 ordinary shares were transferred to him, which he has retained.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

19,855

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2026-05-18

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings